4th Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Draft version of the "INSULIN Act:" provisions on cost-sharing, utilization management and rebates for insulin. H.R. 7666: "The Restoring Hope for Mental Health and Well-Being Act of 2022," Title VI, Sec. 602, Oversight of Pharmacy Benefit Manager Services. Senate Omnibus as Amendment #6552 to H.R. 2617 relating to the Consolidated Appropriations Act, 2023, - possible provisions related to pharmacy benefit managers.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7666 (117th), H.R. 2617 (117th)

Medicare/Medicaid MMM

Draft version of the "INSULIN Act:" provisions on cost-sharing, utilization management and rebates for insulin. H.R. 7666: "The Restoring Hope for Mental Health and Well-Being Act of 2022," Title VI, Sec. 602, Oversight of Pharmacy Benefit Manager Services. Senate Omnibus as Amendment #6552 to H.R. 2617 relating to the Consolidated Appropriations Act, 2023, - possible provisions related to pharmacy benefit managers.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7666 (117th), H.R. 2617 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.